S&P 500   3,821.55
DOW   30,946.99
QQQ   283.54
S&P 500   3,821.55
DOW   30,946.99
QQQ   283.54
S&P 500   3,821.55
DOW   30,946.99
QQQ   283.54
S&P 500   3,821.55
DOW   30,946.99
QQQ   283.54

LHC Group Stock Forecast, Price & News

-2.35 (-1.50%)
(As of 06/28/2022 04:00 PM ET)
Today's Range
50-Day Range
52-Week Range
388,630 shs
Average Volume
512,812 shs
Market Capitalization
$4.80 billion
P/E Ratio
Dividend Yield
Price Target
30 days | 90 days | 365 days | Advanced Chart

Receive LHCG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LHC Group and its competitors with MarketBeat's FREE daily newsletter.

LHCG Stock Forecast (MarketRank)

Overall MarketRank

1.76 out of 5 stars

Medical Sector

645th out of 1,433 stocks

Home Health Care Services Industry

8th out of 9 stocks

Analyst Opinion: 1.0Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -
LHC Group logo


LHC Group, Inc., a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. It operates through five segments: Home Health Services, Hospice Services, Home and Community-Based Services, Facility-Based Services, and Healthcare Innovations (HCI). The Home Health Services segment offers skilled nursing, medically oriented social services and physical, occupational, and speech therapy. The Hospice Services segment provides pain and symptom management accompanied by palliative medication, emotional and spiritual support, inpatient and respite care, homemaker services, dietary counseling, family bereavement counseling, and social worker visits. Its Home and Community-Based Services segment offers range of services, such as assistance with grooming, medication reminders, meal preparation, assistance with feeding, light housekeeping, respite care, transportation, and errand. The Facility-Based Services segment treats patients with severe medical conditions who require a high-level of care and frequent monitoring by physicians and other clinical personnel. This segment serves patients suffering from respiratory failure, neuromuscular and cardiac disorders, non-healing wounds, renal disorders, cancer, head and neck injuries, and mental disorders, as well as treats patients diagnosed with musculoskeletal impairments; and operates nursing facilities, family health center, rural health clinic, and physician practice, as well as offers physical therapy services. The HCI segment provides strategic health management services to accountable care organizations. As of December 31, 2021, it operated 557 home health services locations, 170 hospice locations, 136 community-based service locations, 11 long-term acute care hospitals with 12 locations, and 14 HCI locations. The company was founded in 1994 and is based in Lafayette, Louisiana.

LHCG Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Home health care services
Health Care Services
Current Symbol
Year Founded

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Price Target and Rating

Average Stock Price Forecast
High Stock Price Forecast
Low Stock Price Forecast
Forecasted Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
11 Analysts


Net Income
$115.73 million
Pretax Margin


Sales & Book Value

Annual Sales
$2.22 billion
Cash Flow
$7.41 per share
Book Value
$52.17 per share


Free Float
Market Cap
$4.80 billion

Social Links

LHC Group Frequently Asked Questions

Should I buy or sell LHC Group stock right now?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LHC Group in the last year. There are currently 11 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" LHC Group stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in LHCG, but not buy additional shares or sell existing shares.
View analyst ratings for LHC Group
or view top-rated stocks.

What is LHC Group's stock price forecast for 2022?

11 Wall Street research analysts have issued 1-year price objectives for LHC Group's stock. Their LHCG stock forecasts range from $150.00 to $185.00. On average, they anticipate LHC Group's stock price to reach $167.33 in the next twelve months. This suggests a possible upside of 8.2% from the stock's current price.
View analysts' price targets for LHC Group
or view top-rated stocks among Wall Street analysts.

How has LHC Group's stock performed in 2022?

LHC Group's stock was trading at $137.23 at the beginning of the year. Since then, LHCG stock has increased by 12.7% and is now trading at $154.65.
View the best growth stocks for 2022 here

Are investors shorting LHC Group?

LHC Group saw a increase in short interest during the month of June. As of June 15th, there was short interest totaling 2,710,000 shares, an increase of 24.3% from the May 31st total of 2,180,000 shares. Based on an average daily volume of 720,600 shares, the short-interest ratio is presently 3.8 days. Currently, 9.2% of the company's stock are short sold.
View LHC Group's Short Interest

When is LHC Group's next earnings date?

LHC Group is scheduled to release its next quarterly earnings announcement on Wednesday, August 3rd 2022.
View our earnings forecast for LHC Group

How were LHC Group's earnings last quarter?

LHC Group, Inc. (NASDAQ:LHCG) posted its quarterly earnings data on Wednesday, May, 4th. The health services provider reported $1.09 earnings per share for the quarter, beating analysts' consensus estimates of $1.05 by $0.04. The health services provider had revenue of $571.50 million for the quarter, compared to analysts' expectations of $573.10 million. LHC Group had a trailing twelve-month return on equity of 10.11% and a net margin of 4.44%. The company's revenue was up 8.9% on a year-over-year basis. During the same period last year, the company earned $1.39 EPS.
View LHC Group's earnings history

Who are LHC Group's key executives?

LHC Group's management team includes the following people:
  • Mr. Keith G. Myers, Co-Founder, CEO & Chairman (Age 63, Pay $1M)
  • Mr. Joshua L. Proffitt, Pres & Chief Operating Officer (Age 44, Pay $663k)
  • Mr. Dale Gerard Mackel, Exec. VP, CFO & Treasurer (Age 57, Pay $505.24k)
  • Mr. Nicholas Gachassin III, Exec. VP & Gen. Counsel (Age 55, Pay $418.46k) (LinkedIn Profile)
  • Mr. Bruce D. Greenstein B.S., M.S., Exec. VP and Chief Strategy & Innovation Officer (Age 53, Pay $546.8k)
  • Mr. John L. Indest, Consultant & Independent Director (Age 70, Pay $101.5k)
  • Ms. Kimberly S. Seymour, Sr. VP & Chief Accounting Officer (Age 45)
  • Mr. Mohammad Ali, Chief Information Officer
  • Mr. Marcus D. Macip, Exec. VP & Chief Admin. Officer
  • Ms. JoAnne Little, Sr. VP & Chief Compliance Officer

What is Keith G. Myers' approval rating as LHC Group's CEO?

524 employees have rated LHC Group CEO Keith G. Myers on Glassdoor.com. Keith G. Myers has an approval rating of 87% among LHC Group's employees.

What other stocks do shareholders of LHC Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other LHC Group investors own include Verizon Communications (VZ), NVIDIA (NVDA), Home Depot (HD), Cisco Systems (CSCO), Visa (V), CVS Health (CVS), Johnson & Johnson (JNJ), Alibaba Group (BABA), Chevron (CVX) and Intel (INTC).

What is LHC Group's stock symbol?

LHC Group trades on the NASDAQ under the ticker symbol "LHCG."

Who are LHC Group's major shareholders?

LHC Group's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (15.22%), Vanguard Group Inc. (9.38%), Wellington Management Group LLP (6.78%), Invesco Ltd. (4.12%), State Street Corp (3.23%) and BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp (2.67%). Company insiders that own LHC Group stock include Nicholas Gachassin III, Ronald T Nixon and W Earl Reed III.
View institutional ownership trends for LHC Group

Which institutional investors are selling LHC Group stock?

LHCG stock was sold by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., BlackRock Inc., Eaton Vance Management, TimesSquare Capital Management LLC, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp, Great West Life Assurance Co. Can, Handelsbanken Fonder AB, and Vanguard Group Inc.. Company insiders that have sold LHC Group company stock in the last two years include Nicholas Gachassin III, Ronald T Nixon, and W Earl Reed III.
View insider buying and selling activity for LHC Group
or view top insider-selling stocks.

Which institutional investors are buying LHC Group stock?

LHCG stock was purchased by a variety of institutional investors in the last quarter, including Versor Investments LP, Baird Financial Group Inc., Alpine Associates Management Inc., Allianz Asset Management GmbH, Sumitomo Mitsui Trust Holdings Inc., Chartwell Investment Partners LLC, Bank of New York Mellon Corp, and Bank of America Corp DE.
View insider buying and selling activity for LHC Group
or or view top insider-buying stocks.

How do I buy shares of LHC Group?

Shares of LHCG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is LHC Group's stock price today?

One share of LHCG stock can currently be purchased for approximately $154.65.

How much money does LHC Group make?

LHC Group (NASDAQ:LHCG) has a market capitalization of $4.80 billion and generates $2.22 billion in revenue each year. The health services provider earns $115.73 million in net income (profit) each year or $3.22 on an earnings per share basis.

How many employees does LHC Group have?

LHC Group employs 30,000 workers across the globe.

When was LHC Group founded?

LHC Group was founded in 1994.

How can I contact LHC Group?

LHC Group's mailing address is 901 HUGH WALLIS ROAD SOUTH, LAFAYETTE LA, 70508. The official website for LHC Group is www.lhcgroup.com. The health services provider can be reached via phone at (337) 233-1307, via email at [email protected], or via fax at 337-235-8037.

This page (NASDAQ:LHCG) was last updated on 6/29/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.